Forecasts data is unavailable for this security.
Consensus recommendation
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for CG Oncology Inc have a median target of 65.50, with a high estimate of 86.00 and a low estimate of 51.00. The median estimate represents a 95.70% increase from the last price of 33.47.
High | 156.9% | 86.00 |
Med | 95.7% | 65.50 |
Low | 52.4% | 51.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 31, 2025.
Average growth rate | +35.61% |
More ▼
Revenue history & estimates in USD
Average growth rate | +17,553.24% |
More ▼